Immunizations

Some health professionals are still saying no to the Covid-19 vaccine

33-year-old Bucks executive. Alex Lasry gets COVID vaccine early

Vacid-19 by J&J: how effective is it and when will it be available?

Vaccine hope driven by data from Novavax and J&J, but fears about new variants remain

Novavax’s stock rises as its Covid-19 vaccine outpaces J&J

Novavax stock rises more than 20% after the study of the COVID-19 vaccine shows almost 90% effectiveness in the UK, but less against the new South African variant

The Novavax vaccine is 89% effective against Covid-19 in the UK study

The self-destructive struggle for vaccines in Europe – WSJ

VIRUSES TODAY: Lawmakers ask for racial data on access to vaccines

As the EU fights the shortage of AstraZeneca, the United Kingdom continues to manufacture the new vaccine COVID

Pfizer Covid-19 vaccine works against mutations found in the UK, South Africa variants, laboratory study results

EU clashes with AstraZeneca over Covid-19 vaccine deficit